Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden adds Ozempic to list for Medicare price negotiationIn one of its last actions, the Biden ...

Blockbuster weight loss drug Ozempic could get cheaper by 2027, as it's on the list of medications the government is ...

Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug ...

The Steelers ended in the playoffs, but dropped five in a row to end the year -- and all but one of those defeats came by ...

In 2024, the Rx IP Update team at Smart & Biggar reported on a number of developments in Canadian life sciences IP and ...

Kelly Anne has over six years of experience with reporting and editing in the personal finance space. Her work has been featured in national publications including Reader's Digest, CNBC and Forbes ...

New Jersey-based Hikma Pharmaceuticals USA Inc. is the maker of the generic that just got the go-ahead. The announcement seems to note there is one significant difference some consumers may note: The ...

The Generic PnP monitor driver in Windows allows external monitors to be used without manually installing specific drivers. It defaults to this when it can't find a suitable driver for the monitor ...

While a stuffy nose is a common side effect of oral ED medications, switching from Cialis to shorter-lasting options like ...

Like other medications for the treatment of (ED), Cialis — and its generic version ... these products are unregulated in the United States. Dosage is also critical to your safety.

Dennis feels different - he's an ordinary boy who lives in an ordinary house in an ordinary street, he plays football with his mates and lives with his dad and brother, but he is frustrated by the ...

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...